Sabine Eichinger/LinkedIn
Jul 15, 2026, 13:48
Sabine Eichinger: New Insights into Recurrence Risk After Provoked VTE at ISTH 2026
Sabine Eichinger, Professor at Wien Medicine University, shared on LinkedIn:
”Great presentation by Lisbeth Eischer at ISTH 2026 on the ‘Remaining challenges in secondary VTE prevention’ highlighting the importance of shared decision making.
Our data on the risk of recurrence after provoked VTE support a paradigm shift in how we assess recurrence risk and determine the duration of anticoagulation.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke
-
Oct 18, 2026, 00:07Irem Karaman Sebin: The Evidence Favoring Warfarin in High-Risk Antiphospholipid Syndrome
-
Oct 18, 2026, 00:07Emma Stevens: Lighting Up Buildings in Red and Blue for World Thrombosis Day
-
Oct 17, 2026, 23:18Maha Othman: Establishing ISTH-BAT Reference Ranges for Children and Adolescents
-
Oct 17, 2026, 17:27John Strouse: Building Standards for Whole-Person Sickle Cell Care Through Collaboration
-
Oct 17, 2026, 17:20Jean-Jacques Kiladjian: Exploring the Future of Polycythemia Vera Treatment at MPN Horizons 2026
-
Oct 17, 2026, 17:10Habib Bennaceur: Strengthening Collaboration in Haemophilia, Sickle Cell Disease and Thalassaemia in India